HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,290.00
-10.00 (-0.23%)
Apr 29, 2026, 2:50 PM KST

HLB Life Science Revenue

In the year 2025, HLB Life Science had annual revenue of 45.75B KRW with 39.61% growth. HLB Life Science had revenue of 10.95B in the quarter ending December 31, 2025, with 8.89% growth.

Revenue
45.75B
Revenue Growth
+39.61%
P/S Ratio
11.45
Revenue / Employee
299.03M
Employees
153
Market Cap
523.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202545.75B12.98B39.61%
Dec 31, 202432.77B-65.22B-66.56%
Dec 31, 202397.99B-1.60B-1.61%
Dec 31, 202299.59B46.10B86.17%
Dec 31, 202153.49B-38.30B-41.73%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Korea Electric Power 97.43T
Korea Gas 35.73T
SK eternix 385.64B
Korea District Heating 3,998.19B
Korea Electric Power Industrial Development 394.55B
Samchully Co.,Ltd 5,275.46B
INVENI 1,327.60B
Daesung Energy 1,031.13B
Revenue Rankings